Ruth Mckernan

Insider Reports History

Location
New York, NY
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ruth Mckernan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by Ruth Mckernan